UCB revenue breakdown overview

UCB revenue for the last year amounted to 6.15 B EUR, the most of which — 5.61 B EUR — came from its highest performing source at the moment, Biopharmaceuticals, the year earlier bringing 4.87 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought UCB 3.04 B EUR, and the year before that — 2.45 B EUR.